Martine van Vugt
Direktor/Vorstandsmitglied bei SCANDION ONCOLOGY A/S
Profil
Martine J.
van Vugt is currently an Independent Director at Scandion Oncology A and a Director at Hollandbio.
She is also the Chief Strategy Officer & Executive Vice President at Genmab A.
Additionally, she serves as a Member-Supervisory Board at Flindr Therapeutics BV.
Previously, she was an Independent Member-Supervisory Board at TME Pharma NV.
Dr. van Vugt holds a doctorate degree from the University of Utrecht and a graduate degree from Wageningen University.
Aktive Positionen von Martine van Vugt
| Unternehmen | Position | Beginn |
|---|---|---|
| GENMAB A/S | Corporate Officer/Principal | 29.03.2023 |
| SCANDION ONCOLOGY A/S | Direktor/Vorstandsmitglied | 01.04.2022 |
Immagene BV
 Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
| Hollandbio | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Martine van Vugt
| Unternehmen | Position | Ende |
|---|---|---|
| TME PHARMA N.V. | Direktor/Vorstandsmitglied | 29.06.2023 |
Ausbildung von Martine van Vugt
| Wageningen University | Graduate Degree |
| University of Utrecht | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GENMAB A/S | Health Technology |
| TME PHARMA N.V. | Health Technology |
| SCANDION ONCOLOGY A/S | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Health Technology |
| Hollandbio |
